New York, December 2, 2014 - Elsevier, a world-leading provider of scientific, technical, and medical information products and services, announced today the launch of Journal of Vascular Surgery Cases, a new open access, online-only journal dedicated to publishing peer-reviewed, high quality case reports related to all aspects of arterial, venous, and lymphatic diseases, including the placement and maintenance of arterio-venous dialysis access, with an emphasis on the practicing clinician.
Published by Elsevier on behalf of the Society for Vascular Surgery, the journal seeks to provide novel and timely information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health professionals involved in the management of patients with the entire spectrum vascular disease.
Editors Dr. Anton Sidawy and Dr. Bruce Perler explained, "We are excited that with the launch of Journal of Vascular Surgery Cases we will be able to expand the number of case reports that we publish for the benefit of our readership. At the same time, this new open access journal will allow authors who want to publish their important clinical observations under the banner of the highly respected Journal of Vascular Surgery, but may not have sufficiently sizable clinical series to publish as full clinical reports. We are pleased to work with Elsevier to provide this option as a new forum to researchers and surgeons in the field."
Elizabeth Perill, Executive Publisher at Elsevier said, "We see wonderful opportunities to better serve the vascular surgery community by publishing this new case reports journal in close collaboration with the Society."
For more information, or to submit a paper go to: http://www.
Authors who submit their paper before January 31, 2015 will not be required to pay the publication fee upon acceptance for publication.
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 100 open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).